NIH Funding Opportunities and Notices for January 02, 2015

Dear Colleagues:

See below for some helpful summaries of recent NIH Notices from Jeff Warner at UCOP.  Please read and redistribute as you feel appropriate.

Thank you.


Greg Ruth
Communications Manager
Office of Research


From: Jeffrey Warner <>
Date: January 5, 2015 at 2:34:37 PM EST
Subject: NIH Funding Opportunities and Notices for January 02, 2015
Reply-To: Jeffrey Warner <>

Dear Colleagues:

NOT-OD-15-048 – Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2015

This Notice supersedes NOT-OD-14-046, and establishes stipend levels for fiscal year (FY) 2015 Kirschstein-NRSA awards for undergraduate, predoctoral, and postdoctoral trainees and fellows, as shown in the tables included in the notice.  The Tuition and Fees, Training Related Expenses for trainees, and the Institutional Allowance for individual fellows remain unchanged. This Notice addresses the recommendation of the Biomedical Research Workforce Working Group of the Advisory Committee to the Director, NIH, and reflects the Consolidated and Further Continuing appropriations Act, 2015  (H.R. 83/Public Law 113-235), signed by President Obama on December 16, 2014.


NOT-OD-15-049 – Notice on Salary Limitation on Grants, Cooperative Agreements, and Contracts

This Notice provides information regarding the salary limitation for NIH grant and cooperative agreement awards and extramural research and development contract awards (referred to here as grants). For FY 2015, the Consolidated and Further Continuing Appropriations Act, 2015 (Public Law 113-235), signed into law on December 16, 2014, restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale. The Executive Level II salary is currently set at $181,500, increasing to $183,300 effective January 11, 2015.


NOT-OD-15-050 – NIH Fiscal Policy for Grant Awards – FY2015

This Notice provides guidance about the NIH Fiscal Operations for FY 2015 and implements the  Consolidated and Further Continuing Appropriations Act, 2015  (H.R. 83/Public Law 113-235), signed by President Obama on December 16, 2014.   The Act provides NIH with $30.31 billion in new budget authority or equivalent (program level), an increase of approximately $240 million over the FY 2014 final budget allocations totaling $30.07 billion.  The NIH will continue to manage its portfolio in biomedical research investments in a manner that includes recognizing applications from and providing special incentives for new investigators.

FY 2015 Funding Levels: Non-competing continuation awards that have already been made in FY 2015 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level) as described in NOT-OD-15-001. Such reductions may be fully or partially restored, depending on the Institute or Center.  Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2015 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level. Out-year commitments for continuation awards in FY 2016 and beyond will remain unchanged.  The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2015 funds.

Ruth L. Kirschstein National Research Service Awards (NRSA):  Consistent with the 2015 Consolidated and Further Continuing Appropriations Act and with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by 2 percent on average.  The full range of stipend adjustments for FY 2015 is described at NOT-OD-15-048.

New Investigators: NIH will continue to support new investigators on R01 equivalent awards at success rates comparable to that of established investigators submitting new (Type 1) R01 equivalent applications.  Achievement of comparable success rates should permit the NIH to support new investigators in accordance with the policies established in FY 2009 and subsequent years as described at and at

Salary Limits: Section 203 of the 2015 Consolidated and Further Continuing Appropriations Act prohibits payments for salaries under grants and other extramural mechanisms in excess of Executive Level II currently set at $181,500.  See NOT-OD-14-049 for additional information.



Jeff Warner

Research Policy Analyst
Research Policy Analysis and Coordination
University of California, Office of the President
1111 Franklin St. 11th Floor, 11210C
Oakland, CA 94607

Scroll to Top